A series of novel benzamide derivatives were prepared and evaluated using cell-based measurements. Among these compounds, 10f significantly inhibited Hedgehog signaling and showed equivalent or more potency than GDC-0449 in different tests. Furthermore, compound 10f potently inhibited the proliferation of Daoy, a medulloblastoma cell line that is reported to be resistant to GDC-0449, which indicated a promising prospect in the treatment of Hedgehog signaling pathway related cancer in clinical trial.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2014.01.006 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!